Kintor Pharmaceutical Limited
OTC: KNTPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Youzhi Tong
- Employees
- 168
- Headquarters
- Suzhou, China
- IPO year
- 2020
- Market cap
- $160.4M
- Website
- https://www.kintor.com.cn
Loading KNTPF…
Loading profile data…Frequently asked questions about KNTPF
What does Kintor Pharmaceutical Limited (KNTPF) do?
Kintor Pharmaceutical Limited is a clinical-stage biotechnology firm dedicated to the development and commercialization of a diverse pipeline of small molecule and biologic treatments. Its primary focus is on addressing androgen-receptor-related conditions where current medical options are lacking, serving patients both within the People's Repub...
Where does KNTPF trade?
Kintor Pharmaceutical Limited (KNTPF) trades on the Other OTC.
What sector is KNTPF in?
Kintor Pharmaceutical Limited (KNTPF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kintor Pharmaceutical Limited?
Youzhi Tong is the chief executive officer of Kintor Pharmaceutical Limited (KNTPF).
Where is Kintor Pharmaceutical Limited headquartered?
Kintor Pharmaceutical Limited is headquartered in China.
Does KNTPF pay a dividend?
Kintor Pharmaceutical Limited (KNTPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KNTPF go public?
Kintor Pharmaceutical Limited (KNTPF) completed its initial public offering in 2020.